Jeff Kindler, a biopharma executive who helped steer Pfizer’s $68 billion merger with Wyeth, is looking for a healthy return on his Upper West Side home.
Kindler and his wife, Sharon Sullivan, who works in the performing arts, have listed a four-bedroom, four-bath condo on West 64th Street for $8.5 million, according to an ad that appeared this week.
The 3,700-square-foot unit, which features an 846-square-foot living room, a primary suite with a gas fireplace and an open kitchen with stainless-steel appliances in a 13-story prewar building near Central Park, cost the couple $4.4 million in 2009, based on the city register, or the equivalent of $6.6 in inflation-adjusted 2025 dollars.
Kindler, who assumed the CEO job at Pfizer in 2006, was at the helm in 2010 when the company completed its blockbuster acquisition of rival Wyeth, one of the largest-ever mergers in the industry. Pfizer’s top-selling Lipitor had been scheduled to face stiff competition and a drop in revenue when generic versions of the cholesterol-fighting drug became available from rival drugmakers in 2011.
The Wyeth deal, which brought new products including childhood vaccine Prevnar into Pfizer’s fold, provided a big boost to the Manhattan-based company’s earnings.
In 2013, two years after leaving Pfizer, Kindler became CEO of Centrexion Therapeutics, a Boston-based company focused on using non-opioid products to ease chronic pain. Kindler still holds the position today.
Prior to his stint with Pfizer, Kindler served on President Barack Obama’s six-member management advisory board, a group Obama consulted in shaping the Affordable Care Act, the law that created the subsidized health insurance system known as Obamacare. A recurring target of congressional Republicans for years afterward, Obamacare finds itself in the crosshairs yet again because of the federal budget proposed last month by the House of Representatives, which would reportedly make enrolling in Obamacare plans more difficult.
Kindler’s home may be coming to market at a propitious time. Luxury homes, or those priced at $4 million and above, have enjoyed a strong spring, according to high-end home sales tracker the Olshan luxury market report. In the week ending May 25, for instance, buyers signed 55 contracts for homes in the price bracket. That represented a 77% increase over the previous week, which had 31 deals, the report said.
Douglas Elliman agent Dana Goldman, who is marketing the unit, did not respond to a request for comment by press time.
